75 related articles for article (PubMed ID: 9816219)
21. Enhancement of cisplatin sensitivity by NSC109268 in budding yeast and human cancer cells is associated with inhibition of S-phase progression.
Jain D; Patel N; Shelton M; Basu A; Roque R; Siede W
Cancer Chemother Pharmacol; 2010 Oct; 66(5):945-52. PubMed ID: 20101404
[TBL] [Abstract][Full Text] [Related]
22. Caffeine induces S-phase apoptosis in cis-diamminedichloroplatinum-treated cells, whereas cis-diamminedichloroplatinum induces a block in G2/M.
Shinomiya N; Takemura T; Iwamoto K; Rokutanda M
Cytometry; 1997 Apr; 27(4):365-73. PubMed ID: 9098629
[TBL] [Abstract][Full Text] [Related]
23. Additive effects of amrubicin with cisplatin on human lung cancer cell lines.
Yamauchi S; Kudoh S; Kimura T; Hirata K; Yoshikawa J
Osaka City Med J; 2002 Jun; 48(1):69-76. PubMed ID: 12375699
[TBL] [Abstract][Full Text] [Related]
24. Metronidazole enhances the cytotoxic synergism produced by the combination of 1-beta-arabinofuranosylcytosine and cis-diamminedichloroplatinum.
Trujillo JM; Yang LY; Gercovich G; Su YZ; Lee J
Anticancer Res; 1989; 9(6):1751-6. PubMed ID: 2627125
[TBL] [Abstract][Full Text] [Related]
25. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
[TBL] [Abstract][Full Text] [Related]
26. ZM447439, the Aurora kinase B inhibitor, suppresses the growth of cervical cancer SiHa cells and enhances the chemosensitivity to cisplatin.
Zhang L; Zhang S
J Obstet Gynaecol Res; 2011 Jun; 37(6):591-600. PubMed ID: 21159048
[TBL] [Abstract][Full Text] [Related]
27. [Potentiation and mechanism of cisplatin-induced apoptosis by lidamycin in human hepatoma BEL-7402 cells].
Liu HZ; Li DD; Zhen YS; Shao RG
Yao Xue Xue Bao; 2003 Apr; 38(4):250-4. PubMed ID: 12889121
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
Tanaka T; Masuda H; Naito M; Tamai H
Anticancer Res; 2001; 21(4A):2463-9. PubMed ID: 11724308
[TBL] [Abstract][Full Text] [Related]
29. DNA damage response (DDR) pathway engagement in cisplatin radiosensitization of non-small cell lung cancer.
Sears CR; Cooney SA; Chin-Sinex H; Mendonca MS; Turchi JJ
DNA Repair (Amst); 2016 Apr; 40():35-46. PubMed ID: 26991853
[TBL] [Abstract][Full Text] [Related]
30. Effect of novobiocin on cisplatin cytotoxicity and DNA interstrand cross-link formation in a cisplatin-resistant, small-cell lung carcinoma cell line.
de Jong S; Timmer-Bosscha H; de Vries EG; Mulder NH
Int J Cancer; 1993 Jan; 53(1):110-7. PubMed ID: 8380054
[TBL] [Abstract][Full Text] [Related]
31. Ammonium chloride enhances cisplatin cytotoxicity through DNA double-strand breaks in human cervical cancer cells.
Xu Y; Wang N; Ding Y; Wang C; Yu Y; Liu S; Wang X; Li Z
Oncol Rep; 2013 Sep; 30(3):1195-200. PubMed ID: 23783842
[TBL] [Abstract][Full Text] [Related]
32. Radiation sensitivities in various anticancer-drug-resistant human lung cancer cell lines and mechanism of radiation cross-resistance in a cisplatin-resistant cell line.
Oshita F; Fujiwara Y; Saijo N
J Cancer Res Clin Oncol; 1992; 119(1):28-34. PubMed ID: 1400562
[TBL] [Abstract][Full Text] [Related]
33. Radiation enhancement by 9-aminocamptothecin: the effect of fractionation and timing of administration.
Kirichenko AV; Rich TA
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):659-64. PubMed ID: 10348297
[TBL] [Abstract][Full Text] [Related]
34. Synergistic interaction between cisplatin and gemcitabine in vitro.
Bergman AM; Ruiz van Haperen VW; Veerman G; Kuiper CM; Peters GJ
Clin Cancer Res; 1996 Mar; 2(3):521-30. PubMed ID: 9816199
[TBL] [Abstract][Full Text] [Related]
35. Schedule-dependent antagonism of gemcitabine and cisplatin in human anaplastic thyroid cancer cell lines.
Voigt W; Bulankin A; Müller T; Schoeber C; Grothey A; Hoang-Vu C; Schmoll HJ
Clin Cancer Res; 2000 May; 6(5):2087-93. PubMed ID: 10815936
[TBL] [Abstract][Full Text] [Related]
36. The mechanism of polyamine analog-induced enhancement of cisplatin cytotoxicity in the U-251 MG human malignant glioma cell line.
Paliwal J; Janumpalli G; Basu HS
Cancer Chemother Pharmacol; 1998; 41(5):398-402. PubMed ID: 9523736
[TBL] [Abstract][Full Text] [Related]
37. Synergistic effect and possible mechanisms of tumor necrosis factor and cisplatin cytotoxicity under moderate hyperthermia against gastric cancer cells.
Buell JF; Reed E; Lee KB; Parker RJ; Venzon DJ; Amikura K; Arnold S; Fraker DL; Alexander HR
Ann Surg Oncol; 1997 Mar; 4(2):141-8. PubMed ID: 9084851
[TBL] [Abstract][Full Text] [Related]
38. Camptothecin analogues/cisplatin: an effective treatment of advanced bladder cancer in a preclinical in vivo model system.
Keane TE; El-Galley RE; Sun C; Petros JA; Dillahey D; Gomaa A; Graham SD; McGuire WP
J Urol; 1998 Jul; 160(1):252-6. PubMed ID: 9628659
[TBL] [Abstract][Full Text] [Related]
39. S-phase population analysis does not correlate with the cytotoxicity of camptothecin and 10,11-methylenedioxycamptothecin in human colon carcinoma HT-29 cells.
O'Connor PM; Nieves-Neira W; Kerrigan D; Bertrand R; Goldman J; Kohn KW; Pommier Y
Cancer Commun; 1991 Aug; 3(8):233-40. PubMed ID: 1653585
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin.
Kovacs MS; Hocking DJ; Evans JW; Siim BG; Wouters BG; Brown JM
Br J Cancer; 1999 Jun; 80(8):1245-51. PubMed ID: 10376978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
